iCardiac

I Cardiac

Biotechnology, 1818 Market St, Philadelphia, Pennsylvania, 19103, United States, 1001-5000 Employees

ert.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +15*********

Who is ICARDIAC

iCardiac Technologies was acquired by ERT in December, 2017. ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so that our customers can m...

Read More

map
  • 1818 Market St, Philadelphia, Pennsylvania, 19103, United States Headquarters: 1818 Market St, Philadelphia, Pennsylvania, 19103, United States
  • 1997 Date Founded: 1997
  • 1001-5000 Employees: 1001-5000
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8071 | NAICS Code: 999990 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ICARDIAC

iCardiac Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding ICardiac

Answer: iCardiac's headquarters are located at 1818 Market St, Philadelphia, Pennsylvania, 19103, United States

Answer: iCardiac's phone number is +15*********

Answer: iCardiac's official website is https://ert.com

Answer: iCardiac's revenue is $10 Million to $25 Million

Answer: iCardiac's SIC: 8071

Answer: iCardiac's NAICS: 999990

Answer: iCardiac has 1001-5000 employees

Answer: iCardiac is in Biotechnology

Answer: iCardiac contact info: Phone number: +15********* Website: https://ert.com

Answer: iCardiac Technologies was acquired by ERT in December, 2017. ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so that our customers can move ahead with confidence. With nearly 50 years of clinical and therapeutic experience, we balance knowledge of what works with a vision for whats next, so we can adapt without compromising standards. Powered by the companys EXPERT technology platform, our solutions enhance trial oversight, enable site optimization, increase patient engagement, and measure the efficacy of new clinical treatments while ensuring patient safety. Over the past four years, more than half of all FDA drug approvals came from ERT-supported studies. Pharma companies, Biotechs, and CROs have relied on ERT solutions in over 10,000 studies spanning more than three million patients to date. By identifying trial risks before they become problems, ERT enables customers to bring clinical treatments to patients quickly and with confidence. Follow ERT and learn how you can accelerate clinical development with confidence.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access